Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).

By S. Moe, T. Drüeke, J. Cunningham, Wayne K. Goodman, K. Martin, K. O̸lgaard, S. Ott, S. Sprague, N. Lameire, G. Eknoyan. Kidney International, 2006

1,962 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Disorders of bone remodeling. (2011, methodology): “Primary factors contributing to secondary hyperparathyroidism are hyperphosphatemia, hypocalcemia, and vitamin D deficiency (147, 148).”
ESH / ESC Guidelines for the management of arterial hypertension (2013, background): “function when serum creatinine values are still within the normal range.(211) A reduction in renal function and an increase in CV risk can be inferred from the finding of increased serum levels of cystatin C.”
The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. (2013, background): “These formulae help to detect mild impairment of renal function when serum creatinine values are still within the normal range [211].”
KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) (2017, background): “Renal osteodystrophy is defined as abnormal bone histology and is 1 component of the bone abnormalities of CKDMBD.(29) Bone biopsy is the gold standard for the diagnosis and classification for renal osteodystrophy.”